Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey
复制标题
DOI：
10.1093/cid/ciaa1804
复制
发表时间：
2021-11-01
影响因子：
11.8
通讯作者：
Havers, Fiona P.
中科院分区：
文献类型：
--
作者：
Bajema, Kristina L.;Dahlgren, F. Scott;Havers, Fiona P.
我们比较了2020年4月和5月期间亚特兰大大都市商业实验室残留血清和社区家庭调查估计的严重急性呼吸综合征冠状病毒2型血清阳性率，发现这两个估计值相似（4.94% vs 3.18%）。与更具代表性的调查相比，商业血清可以提供血清阳性率的近似测量。
We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April and May 2020 and found these 2 estimates to be similar (4.94% vs 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.